Analysen zu Apple Inc.
| 04.09.25 | Apple Neutral | UBS AG | |
| 03.09.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 03.09.25 | Apple Neutral | UBS AG | |
| 02.09.25 | Apple Neutral | UBS AG | |
| 08.08.25 | Apple Buy | Goldman Sachs Group Inc. | |
| 07.08.25 | Apple Halten | DZ BANK | |
| 07.08.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 07.08.25 | Apple Neutral | UBS AG | |
| 05.08.25 | Apple Neutral | UBS AG | |
| 01.08.25 | Apple Halten | DZ BANK | |
| 01.08.25 | Apple Hold | Jefferies & Company Inc. | |
| 01.08.25 | Apple Neutral | UBS AG | |
| 01.08.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 30.07.25 | Apple Hold | Jefferies & Company Inc. | |
| 25.07.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 24.07.25 | Apple Neutral | UBS AG | |
| 22.07.25 | Apple Neutral | UBS AG | |
| 21.07.25 | Apple Neutral | UBS AG | |
| 08.07.25 | Apple Neutral | UBS AG | |
| 03.07.25 | Apple Neutral | UBS AG | |
| 01.07.25 | Apple Hold | Jefferies & Company Inc. | |
| 26.06.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 26.06.25 | Apple Neutral | UBS AG | |
| 13.06.25 | Apple Neutral | UBS AG | |
| 10.06.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 09.06.25 | Apple Neutral | UBS AG | |
| 05.06.25 | Apple Neutral | UBS AG | |
| 04.06.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 03.06.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 28.05.25 | Apple Neutral | UBS AG | |
| 23.05.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 23.05.25 | Apple Neutral | UBS AG | |
| 13.05.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 06.05.25 | Apple Neutral | UBS AG | |
| 05.05.25 | Apple Halten | DZ BANK | |
| 02.05.25 | Apple Underperform | Jefferies & Company Inc. | |
| 02.05.25 | Apple Buy | Goldman Sachs Group Inc. | |
| 02.05.25 | Apple Neutral | UBS AG | |
| 30.04.25 | Apple Hold | Jefferies & Company Inc. | |
| 30.04.25 | Apple Hold | Jefferies & Company Inc. | |
| 28.04.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 23.04.25 | Apple Neutral | UBS AG | |
| 22.04.25 | Apple Neutral | UBS AG | |
| 14.04.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 14.04.25 | Apple Neutral | UBS AG | |
| 09.04.25 | Apple Hold | Jefferies & Company Inc. | |
| 07.04.25 | Apple Neutral | UBS AG | |
| 07.04.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 03.04.25 | Apple Underperform | Jefferies & Company Inc. | |
| 01.04.25 | Apple Neutral | UBS AG |
Aktuelle Aktienanalysen
| 05.12.25 | Swiss Re Hold | Jefferies & Company Inc. | |
| 05.12.25 | Swiss Re Underperform | RBC Capital Markets | |
| 05.12.25 | SCHOTT Pharma Buy | UBS AG | |
| 05.12.25 | SCHOTT Pharma Sector Perform | RBC Capital Markets | |
| 05.12.25 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.12.25 | Shell Overweight | JP Morgan Chase & Co. | |
| 05.12.25 | BP Neutral | JP Morgan Chase & Co. | |
| 05.12.25 | TotalEnergies Neutral | JP Morgan Chase & Co. | |
| 05.12.25 | Eni Underweight | JP Morgan Chase & Co. | |
| 05.12.25 | Ahold Delhaize Underweight | JP Morgan Chase & Co. | |
| 05.12.25 | National Grid Overweight | JP Morgan Chase & Co. | |
| 04.12.25 | SCHOTT Pharma Hold | Jefferies & Company Inc. | |
| 04.12.25 | BASF Outperform | Bernstein Research | |
| 04.12.25 | Rio Tinto Overweight | Barclays Capital | |
| 04.12.25 | SCHOTT Pharma Overweight | Barclays Capital | |
| 04.12.25 | SAFRAN Outperform | RBC Capital Markets | |
| 04.12.25 | Airbus Outperform | RBC Capital Markets | |
| 04.12.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 04.12.25 | Verbund Reduce | Baader Bank | |
| 04.12.25 | National Grid Overweight | Barclays Capital | |
| 04.12.25 | Iberdrola Overweight | Barclays Capital | |
| 04.12.25 | Meta Platforms Overweight | JP Morgan Chase & Co. | |
| 04.12.25 | AstraZeneca Outperform | Bernstein Research | |
| 04.12.25 | Stellantis Kaufen | DZ BANK | |
| 04.12.25 | Aurubis Halten | DZ BANK | |
| 04.12.25 | BAT Buy | Jefferies & Company Inc. | |
| 04.12.25 | CTS Eventim Kaufen | DZ BANK | |
| 04.12.25 | L'Oréal Neutral | UBS AG | |
| 04.12.25 | BASF Neutral | UBS AG | |
| 04.12.25 | GSK Neutral | UBS AG | |
| 04.12.25 | Boeing Outperform | RBC Capital Markets | |
| 04.12.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 04.12.25 | Nordea Bank Abp Registered Shs Neutral | Goldman Sachs Group Inc. | |
| 04.12.25 | Intesa Sanpaolo Neutral | Goldman Sachs Group Inc. | |
| 04.12.25 | Salesforce Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | Deutsche Bank Neutral | Goldman Sachs Group Inc. | |
| 04.12.25 | UniCredit Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | ING Group Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | BNP Paribas Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | Santander Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | Commerzbank Neutral | Goldman Sachs Group Inc. | |
| 04.12.25 | BBVA Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | LEG Immobilien Neutral | Goldman Sachs Group Inc. | |
| 04.12.25 | Aroundtown Neutral | Goldman Sachs Group Inc. | |
| 04.12.25 | Vonovia Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | Grand City Properties Neutral | Goldman Sachs Group Inc. | |
| 04.12.25 | Salesforce Overweight | Barclays Capital | |
| 04.12.25 | Inditex Hold | Deutsche Bank AG | |
| 04.12.25 | HUGO BOSS Hold | Deutsche Bank AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.